Nannizziopsis guarroi (NIDO)

Nannizziopsis guarroi, commonly abbreviated as NIDO or sometimes referred to as Yellow Fungus Disease, is a serious dermatomycosis caused by the fungal pathogen Nannizziopsis guarroi. While this infection is most commonly associated with bearded dragons and other agamid lizards, it can also affect snakes and various other reptile species. NIDO represents an emerging fungal pathogen of significant concern in reptile medicine due to its ability to cause progressive, destructive skin disease that can become invasive and even systemic. Unlike many opportunistic fungal infections that only affect immunocompromised hosts, N. guarroi appears capable of causing primary disease in otherwise healthy reptiles, making it a true pathogen rather than merely an opportunist.

In snakes, Nannizziopsis guarroi infections are diagnosed less frequently than in bearded dragons, but documented cases confirm that snakes are susceptible hosts. Various snake species have been affected, though the full range of susceptibility is not yet fully characterized. The infection can spread between reptiles through direct contact or via contaminated environmental surfaces and equipment, making quarantine and hygiene particularly important in collections. The relatively recent emergence of N. guarroi as a recognized reptile pathogen means that awareness among both keepers and veterinarians continues to grow, improving detection rates but also revealing the scope of the problem.

The impact of Nannizziopsis guarroi infection on snake health can be severe and progressive if not addressed early and aggressively. Initial skin lesions can spread across significant portions of the body surface, causing extensive scale damage, tissue necrosis, and secondary infections. In some cases, the fungus penetrates beyond the skin into deeper tissues, and systemic dissemination is possible though less common. The progressive nature of untreated NIDO means that early lesions that might seem manageable can advance to cause devastating tissue destruction. The infection also compromises the snake's protective integument, leading to fluid loss, increased susceptibility to other pathogens, and thermoregulatory difficulties.

Treatment of Nannizziopsis guarroi infection in snakes requires prompt, aggressive intervention combining appropriate antifungal therapy, wound care, and often surgical debridement of affected tissue. The prognosis depends heavily on how early treatment begins and how well the snake responds to therapy. Early-stage infections limited to superficial skin involvement have reasonably good prognosis with aggressive treatment, while advanced disease with deep tissue invasion or extensive spread carries more guarded prognosis. Snake-experienced veterinary care is essential, as accurate diagnosis requires appropriate testing and treatment protocols must be tailored to the individual case. The potential for NIDO to spread between reptiles makes diagnosis and management important not just for the individual animal but for protecting other reptiles in the collection or household.

Nannizziopsis guarroi is a keratinophilic fungus belonging to the family Onygenaceae, closely related to other reptile pathogens in the Nannizziopsis, Paranannizziopsis, and Ophidiomyces genera. This organism has a particular affinity for keratin, the protein that makes up reptile scales, making the integument a primary target for infection. Unlike many environmental fungi that only cause disease in compromised hosts, N. guarroi has demonstrated ability to infect apparently healthy reptiles, suggesting it is a primary pathogen. The fungus produces infectious spores that can survive in the environment and spread between animals. Research into the biology and epidemiology of N. guarroi continues as veterinary scientists work to better understand this emerging pathogen.

Transmission of Nannizziopsis guarroi occurs through direct contact with infected animals or through exposure to contaminated environmental surfaces and materials. Infected reptiles shed fungal spores into their environment, contaminating substrate, enclosure surfaces, furnishings, and equipment. Direct contact between reptiles allows transmission of the organism. Shared equipment, handling by keepers who move between enclosures without adequate hygiene, and housing reptiles in enclosures previously occupied by infected animals can all facilitate spread. The ability of N. guarroi to survive in environmental reservoirs makes thorough disinfection essential when dealing with confirmed cases.

Husbandry factors, while not strictly required for infection given the pathogenic nature of N. guarroi, can influence disease severity and progression. Suboptimal temperatures may suppress immune function and impair the snake's ability to fight infection. Excessive humidity combined with poor ventilation creates conditions that may favor fungal proliferation. Overcrowding increases contact opportunities and environmental contamination. Stress from any source suppresses immune function and may allow more rapid disease progression. While good husbandry alone may not prevent infection in an exposed animal, it supports the immune response and overall resilience.

Risk factors for N. guarroi infection in snakes include exposure to infected reptiles, particularly bearded dragons in which the disease is most common. Collections that house multiple reptile species, especially if quarantine protocols are not rigorous, face elevated risk. Reptile shows, swaps, and other events where animals from different sources come together create exposure opportunities. Purchase of animals from sources with unknown health status or inadequate quarantine practices increases risk. Contact with contaminated equipment or enclosures from other keepers poses transmission risk. Any history of Yellow Fungus Disease in reptiles sharing space or equipment with snakes represents a significant concern.

The disease mechanism involves initial colonization of the skin surface followed by penetration into the keratinized layers of the integument. The fungus produces enzymes that break down keratin, allowing deeper invasion through the scales and into underlying tissue. As infection progresses, there is destruction of scale architecture, tissue necrosis, and inflammatory response that can cause significant damage. Deep tissue invasion occurs when the fungus penetrates beyond the epidermis into subcutaneous tissues and potentially muscle. Systemic spread through blood or lymphatic vessels can lead to internal organ involvement, though this is less common than with some other fungal pathogens. The progressive nature of infection means that early superficial disease, if untreated, typically advances to more severe tissue involvement.

Early warning signs of Nannizziopsis guarroi infection in snakes may be subtle and easily overlooked during routine observation. Initial symptoms often include small areas of scale discoloration, typically appearing as grayish, yellow-brown, or tan patches that differ from the snake's normal coloration. There may be slight roughening or textural changes in affected scales before obvious lesions develop. Focal areas of retained shed that do not resolve with normal humidity support may indicate early skin compromise. Minor changes in the snake's behavior such as increased time spent in humid hides or water bowls might suggest developing skin problems. Regular close inspection during handling is essential for detecting these early changes.

Common visible symptoms of established NIDO infection include distinctive skin lesions that progress from discoloration to crusty, hyperkeratotic plaques or nodules. The affected areas often develop a yellow-brown to brown-black coloration, sometimes with a crusty or roughened surface texture that inspired the Yellow Fungus Disease name used in bearded dragons. Scale architecture becomes disrupted, with affected scales losing their normal shape and surface characteristics. Ulceration may develop as tissue necrosis progresses, exposing underlying dermis. The margins of lesions are often irregular and may show surrounding areas of abnormal scale appearance indicating spreading infection. Multiple discrete lesions may be present or lesions may coalesce into larger affected areas.

Behavioral changes in snakes with Nannizziopsis guarroi infection reflect both skin discomfort and systemic effects of disease. Anorexia is common, with affected snakes often showing reduced or absent feeding response. Decreased activity and increased time spent hiding suggest general malaise. The snake may seek out humid areas or spend more time soaking, attempting to ease skin discomfort. Some snakes become more defensive or irritable when handled, possibly due to skin sensitivity. Others may become unusually lethargic and tolerant of handling as illness progresses. Changes from the individual's normal behavioral patterns warrant attention and investigation.

Physical signs beyond primary skin lesions include localized swelling around affected areas indicating tissue inflammation. Discharge or exudate from lesions may occur, particularly from ulcerated areas. Regional lymph node enlargement may be detectable on palpation if infection is spreading. Weight loss becomes apparent with prolonged anorexia. General poor body condition with dull coloration and reduced muscle tone develops in chronic or severe cases. Subcutaneous nodules may indicate deeper tissue involvement. With advanced disease, edema or swelling in body regions without obvious skin lesions may suggest systemic effects.

Shedding abnormalities frequently accompany Nannizziopsis guarroi infection and can serve as diagnostic clues. Dysecdysis with retained shed adherent to lesion sites is very common, as damaged skin cannot complete normal shedding. The shed skin itself may appear abnormal, with discolored patches, thickened areas, or unusual texture corresponding to affected areas. Retained eye caps may occur if infection affects the spectacle region. Increased shedding frequency may occur as the skin attempts to heal and replace damaged tissue. Any unexplained shedding difficulties in a snake that previously shed normally should prompt investigation for underlying skin disease.

Emergency symptoms requiring immediate veterinary attention include rapid spread of lesions with extensive skin involvement. Deep ulceration with exposure of muscle or other underlying structures indicates severe tissue destruction. Signs of systemic illness such as severe lethargy, respiratory changes, or abnormal posture suggest disease has progressed beyond localized skin involvement. Extensive tissue necrosis with black, gangrenous-appearing areas represents advanced disease. Secondary bacterial infection with purulent discharge, foul odor, or dramatically increased swelling requires urgent attention. Any snake with suspected NIDO showing signs of systemic compromise should receive emergency veterinary care.

Physical examination by a snake-experienced veterinarian is the essential starting point for diagnosing suspected Nannizziopsis guarroi infection. The veterinarian conducts thorough examination of the entire body surface, documenting all lesions including location, size, appearance, and characteristics. The clinical appearance of lesions may suggest fungal etiology, though definitive diagnosis requires laboratory confirmation. Assessment of overall health status including body condition, hydration, and any signs of systemic illness helps determine disease severity. Documentation with photographs provides baseline information for monitoring treatment response. The history of potential exposure to other reptiles, particularly bearded dragons or animals with known fungal disease, informs the diagnostic workup.

Definitive diagnosis of Nannizziopsis guarroi infection requires laboratory identification of the organism from affected tissue. Fungal culture from skin biopsy or lesion samples, while the traditional diagnostic approach, can be challenging because N. guarroi may be slow-growing or outcompeted by contaminants. PCR testing for N. guarroi provides rapid, specific identification and is increasingly the preferred diagnostic method when available. Histopathology of skin biopsy demonstrates characteristic fungal invasion patterns and tissue response, supporting the diagnosis even if culture is unsuccessful. Cytology from skin scrapes may reveal fungal elements, though they cannot distinguish N. guarroi from other fungi without additional testing. The combination of compatible clinical presentation, histopathology, and ideally molecular confirmation provides the most definitive diagnosis.

Husbandry and history review is important for understanding the context of infection and identifying potential sources of exposure. The veterinarian will inquire about any contact with other reptiles, particularly bearded dragons or animals with known skin disease. Recent acquisitions, show attendance, or use of shared equipment should be discussed. Current husbandry parameters including temperature, humidity, and sanitation practices are assessed. History of any previous skin problems or treatments provides context. Understanding the potential source of infection helps inform both treatment of the individual and prevention of spread to other animals.

Differential diagnosis for suspected NIDO in snakes includes other dermatomycoses such as Ophidiomyces ophidiicola (Snake Fungal Disease), Chrysosporium species, or other fungal skin infections. Bacterial scale rot and dermatitis can produce similar lesions and must be differentiated through appropriate testing. Thermal burns cause skin damage that might be confused with infectious disease. Neoplastic conditions affecting the skin require biopsy for differentiation. Some viral infections can cause skin abnormalities. Parasitic infections, though typically different in appearance, should be considered. Accurate diagnosis is essential because treatment approaches and prognosis differ significantly between causes, and NIDO has transmission implications that other conditions may not share. Blood work helps assess overall health and may reveal evidence of systemic inflammation or organ involvement in advanced cases.

Husbandry optimization supports treatment of Nannizziopsis guarroi infection and is essential for successful outcomes, though it alone is not sufficient to treat this primary pathogen. Temperature should be maintained at appropriate levels for the species, potentially slightly elevated within safe limits to support immune function. Humidity requires careful management, maintaining levels that support shedding without creating excessive moisture that might favor fungal growth. Substrate should be changed to clean, easily sanitized material during treatment, with many veterinarians recommending paper substrates. The snake should be isolated from other reptiles to prevent transmission. Thorough disinfection of the enclosure and all equipment is necessary, with consideration given to replacing porous items that cannot be adequately decontaminated.

Medical management of NIDO requires appropriate antifungal therapy selected based on knowledge of N. guarroi susceptibility patterns. Voriconazole is often the antifungal of choice for Nannizziopsis infections due to good activity against this organism and reasonable penetration into skin and deeper tissues. Itraconazole may also be effective and is sometimes used as alternative or adjunctive therapy. Terbinafine has activity against dermatophytes and keratinophilic fungi and may be used in combination protocols. Antifungal selection should be guided by culture and sensitivity results when available, though empiric therapy is often initiated while awaiting results. Dosing requires careful calculation based on snake weight and species-specific pharmacokinetics, with treatment typically continuing for weeks to months beyond apparent clinical resolution.

Surgical debridement is often an important component of NIDO treatment, particularly for lesions with significant tissue necrosis or hyperkeratotic buildup. Removal of dead tissue and fungal debris reduces the pathogen burden and allows antifungal medications to better penetrate remaining affected tissue. Debridement should extend to margins of healthy tissue when possible to ensure complete removal of infected material. Multiple debridement procedures may be necessary as treatment progresses and the full extent of involvement becomes apparent. The veterinarian determines the appropriate extent and timing of surgical intervention based on lesion characteristics and the snake's overall condition.

Topical antifungal treatment is typically used in conjunction with systemic therapy for accessible skin lesions. Antifungal solutions, creams, or ointments may be applied directly to lesions following veterinary guidance. Gentle cleaning of lesions with dilute antiseptic solutions helps remove debris and fungal material. The frequency of topical application depends on the products used and severity of disease. Care should be taken to avoid excessive moisture or occlusion that might favor fungal growth. Topical therapy alone is generally insufficient for established NIDO infections but provides valuable adjunctive benefit.

Species-specific considerations affect treatment protocols for snakes with NIDO. Drug metabolism varies between species, potentially affecting dosing intervals. The snake's size influences both drug dosing and surgical options. Concurrent health conditions may affect ability to tolerate aggressive treatment. Gravid females present particular challenges regarding medication safety for developing offspring. The snake's temperament and stress tolerance affect decisions about handling frequency for treatments and examinations. Close communication with the treating veterinarian allows individualization of treatment protocols based on the specific case.

Treatment timeline for Nannizziopsis guarroi infection is typically prolonged, reflecting the persistent nature of this fungal pathogen. Visible improvement in lesions may take several weeks to become apparent. Antifungal therapy commonly continues for three to six months or longer, typically extending at least four to six weeks beyond apparent clinical resolution. Premature discontinuation of treatment is a common cause of relapse. Regular follow-up examinations allow monitoring of treatment response and determination of appropriate treatment endpoints. Repeat diagnostics may be performed to confirm fungal elimination before stopping therapy. The commitment to extended treatment is necessary for successful outcomes.

Recovery timeline for snakes treated for Nannizziopsis guarroi infection varies depending on disease extent at diagnosis and response to treatment. Early-stage infections limited to superficial skin involvement may show significant improvement within four to eight weeks, though treatment continues much longer. More advanced disease with deeper tissue involvement or extensive spread requires longer treatment and recovery periods, often four to six months or more. Complete healing of damaged skin may take several shed cycles after infection is controlled. Keepers must be prepared for an extended treatment and recovery process, understanding that patience and consistency are essential for successful outcomes.

Post-treatment husbandry maintenance is critical for preventing recurrence and supporting complete recovery. The environmental improvements implemented during treatment should become permanent standards of care. Substrate management, sanitation practices, and temperature and humidity control must be consistently maintained. The treated snake should remain isolated from other reptiles until confirmed clear of infection to prevent potential transmission. Enclosure and equipment disinfection should be thorough, with particular attention to any porous materials that might harbor fungal spores. Regular monitoring for any signs of recurrence should continue long after treatment ends.

Prognosis factors for NIDO recovery include the extent of infection at diagnosis, timing of treatment initiation, the snake's overall health and immune status, and adherence to treatment protocols. Early-stage infections in otherwise healthy snakes that receive prompt, appropriate treatment have good prognosis for recovery. Advanced disease with deep tissue involvement or extensive spread carries more guarded prognosis. Delayed treatment allows disease progression that may be difficult to reverse. Underlying conditions that impair immune function reduce the snake's ability to participate in fighting infection. Response to initial treatment provides valuable prognostic information, with steady improvement suggesting favorable outcome.

Feeding resumption guidelines during recovery should follow veterinary recommendations based on the individual case. Snakes that maintained appetite during treatment can generally continue normal feeding schedules. Those that became anorexic should have feeding reintroduced gradually once their condition stabilizes. Appropriate warm-side temperatures must be verified before offering prey to ensure proper digestion. Return of normal feeding behavior is a positive indicator during recovery. Nutritional support aids tissue healing and immune function but should be balanced against the stress of feeding. Patience may be needed, as some snakes require extended periods before normal feeding resumes.

Quarantine protocols are the cornerstone of preventing Nannizziopsis guarroi introduction into snake collections, given the transmissible nature of this pathogen. All newly acquired reptiles should be quarantined in separate enclosures, ideally in a separate room, for a minimum of 90 days before contact with established animals. During quarantine, animals should be observed closely for any skin abnormalities, with veterinary examination recommended. Quarantine should be extended for any animals with questionable health status. New arrivals that came from sources with known or suspected NIDO should receive veterinary evaluation including appropriate diagnostic testing before being considered for introduction. Strict hygiene including dedicated equipment and thorough handwashing between quarantine and main collection areas prevents inadvertent pathogen transfer.

Source screening helps reduce the risk of acquiring infected animals. Purchase reptiles only from reputable sources with good husbandry practices and health monitoring. Ask sellers about any history of fungal disease in their collection or animals they have acquired. Avoid purchasing animals that appear unhealthy or have visible skin abnormalities. Animals from sources with unknown health status or inadequate quarantine practices represent higher risk. Be particularly cautious when acquiring animals that have had contact with bearded dragons or other reptiles known to be susceptible to NIDO. While no screening method is perfect, informed sourcing reduces risk significantly.

Environmental hygiene prevents accumulation of pathogens in the environment and reduces transmission risk. Regular cleaning and disinfection of enclosures, water bowls, and furnishings removes potential fungal contamination. Substrate should be changed regularly and immediately if contamination is suspected. Equipment should be dedicated to individual animals or thoroughly disinfected between uses. Disinfectants effective against fungal organisms should be used, with adequate contact time per product instructions. Hand hygiene between handling different animals prevents inadvertent transmission. These practices are important even in collections without known NIDO, as prevention is far easier than treatment.

Collection management practices minimize transmission risk and support early detection. Avoid housing snakes with bearded dragons or other reptiles known to be commonly affected by NIDO. Maintain separation between animals from different sources until health status is established. New animals should be the last handled each day, with thorough handwashing afterward. Regular health monitoring of all animals allows early detection of any skin abnormalities. Staff training in collections or breeding facilities ensures everyone understands prevention protocols. Documentation of animal health and any concerns facilitates tracking of potential problems.

Veterinary relationship establishment provides access to diagnostic capabilities and treatment when needed. Regular health examinations allow detection of subtle skin changes before they become severe. Any suspicious skin lesions should prompt veterinary consultation rather than waiting to see if they resolve. A relationship with a veterinarian experienced in reptile medicine ensures appropriate diagnostic testing and treatment will be available. Early intervention in potential NIDO cases dramatically improves prognosis and reduces transmission risk. Veterinary guidance on biosecurity and prevention measures helps collections implement best practices.

Ongoing husbandry requirements for snakes that have recovered from NIDO or those in collections with history of this disease emphasize stringent biosecurity and environmental management. Enclosure cleanliness must be maintained through regular spot cleaning and periodic thorough disinfection. Substrate should be kept clean and changed frequently, with consideration given to materials that can be easily sanitized or disposed of. Water bowls require daily cleaning with fresh water. All enclosure surfaces and furnishings need regular disinfection using products effective against fungal organisms. A consistent and rigorous cleaning schedule becomes essential standard practice.

Environmental monitoring ensures conditions remain appropriate and do not favor fungal problems. Temperature should be verified regularly using reliable thermometers at both warm and cool enclosure zones. Humidity monitoring prevents both excessive moisture and inadequate humidity. Environmental parameters should be logged to identify any drift in conditions. Equipment including heating elements, thermostats, and any humidity control systems should be checked regularly for proper function. Immediate correction of any environmental deviations protects against conditions that might favor fungal survival or growth.

Health indicator monitoring for snakes with NIDO history includes heightened attention to skin condition and any changes that might indicate recurrence. Regular close examination during handling sessions should evaluate all body surfaces for discoloration, texture changes, or developing lesions. Shedding should be monitored for completeness, with retained shed warranting investigation. Feeding response, activity patterns, and general behavior serve as indicators of overall health. Any abnormalities should prompt immediate veterinary consultation given the potential for NIDO recurrence. The threshold for seeking veterinary evaluation should remain low.

Collection-wide considerations apply when NIDO has been diagnosed in any reptile within a collection. Enhanced biosecurity protocols protect unaffected animals. Animals that had any contact with the infected individual should be monitored closely for signs of disease. Equipment that was shared must be thoroughly disinfected or replaced. Consideration should be given to testing apparently healthy contact animals. The implications of NIDO diagnosis extend beyond the individual case to the entire collection management approach. Veterinary guidance helps determine appropriate monitoring and prevention measures for the specific situation.

Long-term care planning acknowledges the ongoing vigilance required after NIDO diagnosis. Good husbandry practices must be maintained consistently to prevent recurrence and protect other animals. Record keeping of the disease episode, treatment, and ongoing health observations provides valuable reference. Financial planning for potential veterinary care ensures resources for diagnostic testing and treatment if problems develop. The experience of managing NIDO often transforms keepers into more knowledgeable, biosecurity-conscious practitioners. Sharing experiences with the reptile keeping community contributes to collective understanding of this emerging pathogen and best practices for prevention and management.

High-risk species for Nannizziopsis guarroi infection include primarily bearded dragons and other agamid lizards, though snakes and various other reptiles can be affected. Among snakes, documented cases have occurred in various species, though the full range of susceptibility is not yet characterized. Ball pythons, corn snakes, and other commonly kept species have been diagnosed with NIDO, confirming that snakes are not immune to this pathogen. Any snake that has contact with bearded dragons or other reptiles commonly affected by NIDO faces elevated exposure risk. Snakes in collections that house multiple reptile species may have increased risk due to potential cross-species transmission. Animals acquired from sources with inadequate biosecurity or quarantine practices face higher risk of exposure.

Boid-specific considerations in the context of NIDO relate primarily to the importance of maintaining strict quarantine and biosecurity protocols that also protect against Inclusion Body Disease. While NIDO is a distinct pathogen from IBD, the quarantine practices essential for preventing IBD introduction into boid collections also provide protection against NIDO and other transmissible diseases. Any python or boa showing skin abnormalities requires thorough diagnostic workup to differentiate between various possible causes including fungal infections like NIDO, Ophidiomyces (SFD), and bacterial dermatitis, while also considering IBD-related immunosuppression as a potential contributing factor. Strict quarantine of all new boid acquisitions protects against multiple disease threats simultaneously.

Species-specific susceptibilities to NIDO in snakes remain incompletely characterized as research continues into this relatively recently recognized pathogen. Individual immune status appears important, with immunocompromised animals likely more susceptible to infection and severe disease. Species with particular humidity or substrate requirements that might favor fungal exposure could face elevated risk in certain husbandry situations. Environmental factors including temperature, humidity, and sanitation likely influence disease dynamics across all species. The key point is that no snake species should be considered immune to NIDO, and biosecurity practices should be implemented regardless of the species kept.

Commonly co-occurring conditions with Nannizziopsis guarroi infection include secondary bacterial infections that opportunistically colonize tissue damaged by fungal disease. Skin lesions from NIDO provide entry points for bacteria, potentially leading to mixed infections requiring both antifungal and antibacterial treatment. Dysecdysis frequently accompanies skin disease, as damaged tissue cannot shed normally. Dehydration may develop due to compromised skin barrier function and decreased oral intake. General debilitation from prolonged illness and anorexia compounds the challenges of fighting infection. Secondary complications often affect prognosis and complicate treatment management.

Conditions with similar symptoms that must be differentiated from NIDO include Ophidiomyces ophidiicola infection, commonly known as Snake Fungal Disease (SFD), which causes skin lesions in snakes with potentially similar appearance but is caused by a different fungal pathogen and may have different treatment responses. Other dermatomycoses including Chrysosporium species, Fusarium, and Aspergillus can cause fungal skin disease requiring specific identification. Bacterial dermatitis and scale rot produce skin lesions that may resemble fungal infection. Thermal burns cause skin damage that could be confused with infectious disease. Neoplastic conditions affecting skin require biopsy for differentiation. Accurate diagnosis through appropriate laboratory testing is essential for effective treatment, as antifungal selection and prognosis differ between various fungal infections.

Secondary complications of NIDO include progression to deep tissue invasion when superficial infection is not adequately controlled, with potential involvement of muscle, bone, or internal organs. Systemic dissemination through blood or lymphatic spread can occur in advanced cases, carrying grave prognosis. Permanent scarring and scale abnormalities often result from healed lesions. Functional limitations may occur if extensive tissue damage affects mobility or other functions. Transmission to other reptiles represents a significant concern that extends the impact beyond the individual animal. In collections with valuable animals, the biosecurity implications of NIDO diagnosis may be substantial. Early detection and aggressive treatment minimize the risk of severe complications and transmission.